drugset / Trial / NCT04317209
A Study of SHR0410 in Hemodialysis Patients With Pruritus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to evaluate the safety, tolerability and pharmacokinetics of SHR0410 in hemodialysis patients with moderate to severe pruritus
Timeline
- Start
- 2020-05-17
- Primary completion
- 2020-12
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR0410 | Unknown | — | Intravenous |
Indications
No indication recorded.